The exposure of autoantigens by microparticles underlies the formation of potent inflammatory components: the microparticle‐associated immune complexes
Open accessThe DOI matches its Crossref record; 73 of the 73 references it cites were found in a registry or an index.
Abstract
Immunoglobulins, antigens and complement can assemble to form immune complexes (IC). ICs can be detrimental as they propagate inflammation in autoimmune diseases. Like ICs, submicron extracellular vesicles termed microparticles (MP) are present in the synovial fluid from patients affected with autoimmune arthritis. We examined MPs in rheumatoid arthritis (RA) using high sensitivity flow cytometry and electron microscopy. We find that the MPs in RA synovial fluid are highly heterogeneous in size. The observed larger MPs were in fact MP‐containing ICs (mpICs) and account for the majority of the detectable ICs. These mpICs frequently express the integrin CD41, consistent with platelet origin. Despite expression of the Fc receptor FcγRIIa by platelet‐derived MPs, we find that the mpICs form independently of this receptor. Rather, mpICs display autoantigens vimentin and fibrinogen, and recognition of these targets by anti‐citrullinated peptide antibodies contributes to the production of mpICs. Functionally, platelet mpICs are highly pro‐inflammatory, eliciting leukotriene production by neutrophils. Taken together, our data suggest a unique role for platelet MPs as autoantigen‐expressing elements capable of perpetuating formation of inflammatory ICs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

![Figure 2 Visualization of the mpICs in RA SF Cryo-TEM detection of immunoglobulins and phosphatidylserine exposing MPs using, respectively protein A-conjugated gold nanoparticles (10 nm) and Annexin-V-conjugated gold nanoparticles (4 nm). A,B. Representative observations obtained using RA SF in which MPs [white boxes labelled MP (MP 1 and MP 2 (A) and MP (B)] were colocalized with ∼2 µm diameter mpICs. White arrows indicate the edge of the IC where MPs were detected. Black arrows indicate the carbon matrix of the perforated support film used for TEM. Insets (bottom panels) include individual MPs. Immunoglobulins detected using protein A conjugated nanospheres (10 nm) are indicated with white arrowheads and MPs detected using Annexin-V conjugated nanospheres (4 nm) are indicated by black arrowheads. Note that some MPs were Annexin-V negative.C. Relatively smaller mpICs were also visualized. White and black arrowheads indicate immunoglobulins and phosphatidylserine, respectively. Scale bars are presented under each panel.](https://figures.cochat.ai/paper-figures/af51c7bd10bc4ec891c9d1eac707a31f/the-exposure-of-autoantigens-by-microparticles-underlies-the-formation-of-potent-figure-2.jpg)




![Figure 7 Platelet mpICs promote leukotriene production by neutrophils Quantifications of the leukotriene biosynthesis by neutrophils incubated in presence of RA SF mpICs [n = 3 distinct patients ***p < 0.0001 patients 1 and 2; **p = 0.0011 patient 3 (unpaired t-test, relative to PBS control)]. Data are mean ± SEM. Leukotrienes measured represent the sum of LTB4, 6-trans-LTB4, 12-epi-6-trans-LTB4, 20-OH-LTB4 and 20-COOH-LTB4.Platelet mpICs form promptly upon co-incubation of platelet MPs with anti-fibrinogen in vitro. Representative FSC-PMT and SSC dot plot of mpICs. The presence of mpICs formed in vitro was demonstrated using a combination of FITC-conjugated Annexin-V and Alexa 647-conjugated secondary antibody. The four-quadrant gates were positioned according to the isotypic controls. The MPs (Annexin-V+-IgG−) presented in blue show dimensions ranging mostly from 100 to 500 nm (lower inset) while the mpICs (Annexin-V+-IgG+) presented in purple display dimensions ranging from 800 to 3000 nm (upper inset). The relative dimensions are presented according to size-defined microsphere calibrations.Quantifications of the leukotriene biosynthesis by neutrophils incubated in presence of in vitro mpICs, anti-fibrinogen and platelet MPs. The stimulatory potency of mpICs compared to the others conditions was statistically significant [n = 3 ***p ≤ 0.0001 (unpaired t-test)]. Data are mean ± SEM. Leukotrienes measured represent the sum of LTB4, 6-trans-LTB4, 12-epi-6-trans-LTB4, 20-OH-LTB4 and 20-COOH-LTB4.](https://figures.cochat.ai/paper-figures/b94d7eb7fb544300bab788352d2a97d8/the-exposure-of-autoantigens-by-microparticles-underlies-the-formation-of-potent-figure-7.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The plasma of patients with SLE contains elevated levels of extracellular vesicle-containing immune complexes compared with healthy individuals, the presence of which is associated with anti-dsDNA antibodies, pro-inflammatory cytokines and disease activity213–217.”
From The role of mitochondria in rheumatic diseases (2022) · cites this paper as [213]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Extracellular vesicles, also referred to microparticles, can also contain mitochondria and can associate with antibodies, forming large extracellular vesicle-containing immune complexes213.”
From The role of mitochondria in rheumatic diseases (2022) · cites this paper as [213]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cluster analysis and display of genome-wide expression patterns
Eisen, M. B., Spellman, P. T., Brown, P. O., & Botstein, D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.25.14863 · Cited by 16,184 · cited 1×
“Results were displayed in Java TreeView 1 (Version 1.1.3; Eisen et al, 1998).”
InfluentialIsolation of mononuclear cells and granulocytes from human blood.
Bøyum, A. (1968) · Scandinavian Journal of Clinical and Laboratory Investigation · Cited by 9,585
Membrane vesicles, current state-of-the-art: emerging role of extracellular vesicles
György, B., Szabó, T. G., Pásztói, M., Pál, Z., Misják, P., Aradi, B., László, V., Pállinger, É., Pap, E., Kittel, Á., et al. (2011) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-011-0689-3 · Cited by 2,074
The Nature and Significance of Platelet Products in Human Plasma
Wolf, P. (1967) · British Journal of Haematology · doi:10.1111/j.1365-2141.1967.tb08741.x · Cited by 1,720
Platelets and the immune continuum
Semple, J. W., Italiano, J. E., & Freedman, J. (2011) · Nature Reviews Immunology · doi:10.1038/nri2956 · Cited by 1,692 · cited 1×
“Platelets are highly potent producers of MPs and there is a growing appreciation of the role of platelets in immunity (Boilard et al, 2012; Semple et al, 2011).”
Platelets Amplify Inflammation in Arthritis via Collagen-Dependent Microparticle Production
Boilard, E., Nigrovic, P. A., Larabee, K., Watts, G. F. M., Coblyn, J. S., Weinblatt, M. E., Massarotti, E. M., Remold-O’Donnell, E., Farndale, R. W., Ware, J., et al. (2010) · Science · doi:10.1126/science.1181928 · Cited by 1,085 · cited 9×
“Considering their role in arthritis (Boilard et al, 2010, 2012), we queried whether platelet MPs contribute significantly to mpICs in RA SF.”
InfluentialSelf-citationRuiz-Irastorza, G., Crowther, M., Branch, W., & Khamashta, M. A. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60709-x · Cited by 831
From Systemic T Cell Self-Reactivity to Organ-Specific Autoimmune Disease via Immunoglobulins
Korganow, A.-S., Ji, H., Mangialaio, S., Duchatelle, V., Pelanda, R., Martin, T., Degott, C., Kikutani, H., Rajewsky, K., Pasquali, J.-L., et al. (1999) · Immunity · doi:10.1016/s1074-7613(00)80045-x · Cited by 690 · cited 2×
“ICs are also present in multiple inflammatory autoimmune disorders and are reported to propagate disease (Cross et al, 2001; Ho et al, 2010; Korganow et al, 1999; Kuhn et al, 2006; Monach et al, 2009; Munoz et al, 2010; Ruiz-Irastorza et al, 2010; Stuart & Dixon, 1983; Voulgarelis & Tzioufas, 2010;…”
Autoantigen microarrays for multiplex characterization of autoantibody responses
Robinson, W. H., DiGennaro, C., Hueber, W., Haab, B. B., Kamachi, M., Dean, E. J., Fournel, S., Fong, D., Genovese, M. C., De Vegvar, H. E. N., et al. (2002) · Nature Medicine · doi:10.1038/nm0302-295 · Cited by 673 · cited 1×
“Using an autoantigen microarray (Hueber et al, 2005; Robinson et al, 2002), we demonstrate that the IgG from platelet mpICs associate with a broad series of recognized citrullinated autoantigens (Fig 6A).”
Self-citationTHE BIOLOGICAL SIGNIFICANCE OF THE THROMBOPLASTIC PROTEIN OF BLOOD
Chargaff, E., & West, R. (1946) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)34997-9 · Cited by 659
The role of defective clearance of apoptotic cells in systemic autoimmunity
Muñoz, L. E., Lauber, K., Schiller, M., Manfredi, A. A., & Herrmann, M. (2010) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2010.46 · Cited by 627 · cited 6×
“They are extremely potent at eliciting inflammatory responses and implicated in response to infections as well as multiple autoimmune diseases such as Sjo¨gren’s syndrome (Voulgarelis & Tzioufas, 2010), SLE (Munoz et al, 2010), multiple sclerosis (Cross et al, 2001; Ziemssen & Ziemssen, 2005), antiphospholipid syndrome…”
InfluentialAntibodies against citrullinated proteins enhance tissue injury in experimental autoimmune arthritis
Kuhn, K. A. (2006) · Journal of Clinical Investigation · doi:10.1172/jci25422 · Cited by 534 · cited 3×
“…present in multiple inflammatory autoimmune disorders and are reported to propagate disease (Cross et al, 2001; Ho et al, 2010; Korganow et al, 1999; Kuhn et al, 2006; Monach et al, 2009; Munoz et al, 2010; Ruiz-Irastorza et al, 2010; Stuart & Dixon, 1983; Voulgarelis & Tzioufas, 2010; Zhao et al,…”
Influentialvan der Vlist, E. J., Nolte-'t Hoen, E. N. M., Stoorvogel, W., Arkesteijn, G. J. A., & Wauben, M. H. M. (2012) · Nature Protocols · doi:10.1038/nprot.2012.065 · Cited by 532
Sokolove, J., Bromberg, R., Deane, K. D., Lahey, L. J., Derber, L. A., Chandra, P. E., Edison, J. D., Gilliland, W. R., Tibshirani, R. J., Norris, J. M., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035296 · Cited by 516 · cited 1×
“The remainder of the assay was performed as previously described (Sokolove et al, 2012) and the scores calculated.”
Self-citationHistones induce rapid and profound thrombocytopenia in mice
Fuchs, T. A., Bhandari, A. A., & Wagner, D. D. (2011) · Blood · doi:10.1182/blood-2011-01-332676 · Cited by 430 · cited 1×
“Histones may be associated with DNA, itself bound to MPs. Alternatively, histones are recognized potent platelet stimuli and can associate with platelets directly (Fuchs et al, 2011).”
Structural basis for Ca2+-induced activation of human PAD4
Arita, K., Hashimoto, H., Shimizu, T., Nakashima, K., Yamada, M., & Sato, M. (2004) · Nature Structural & Molecular Biology · doi:10.1038/nsmb799 · Cited by 424 · cited 1×
“Specifically, citrullination is a posttranslational modification of peptidyl-arginine to peptidyl-citrulline by peptidyl arginine deiminase (PAD) enzymes; in RA SF, the PAD4 isoform levels are significantly elevated (Arita et al, 2004; Lundberg et al, 2005).”
Serum transfer of collagen-induced arthritis in mice.
Stuart, J. M., & Dixon, F. J. (1983) · The Journal of experimental medicine · doi:10.1084/jem.158.2.378 · Cited by 414 · cited 3×
“…Distler & Distler, 2010; Distler et al, 2005a; Messer et al, 2009; Reich et al, 2011) and IC (Ho et al, 2010; Korganow et al, 1999; Kuhn et al, 2006; Stuart & Dixon, 1983) when taken separately, our identification of mpICs in synovial fluid uncovers a previously unappreciated physiology of potential…”
György, B., Módos, K., Pállinger, É., Pálóczi, K., Pásztói, M., Misják, P., Deli, M. A., Sipos, Á., Szalai, A., Voszka, I., et al. (2011) · Blood · doi:10.1182/blood-2010-09-307595 · Cited by 409 · cited 13×
“These uncommon features permit the detection of MPs cytofluorometrically by employing Annexin-V (which recognizes phosphatidylserine) conjugated to fluorochromes and size discrimination (Connor et al, 2010; Gyorgy et al, 2011a; Perez-Pujol et al, 2007; Thiagarajan & Tait, 1991).”
InfluentialLACROIX, R., JUDICONE, C., PONCELET, P., ROBERT, S., ARNAUD, L., SAMPOL, J., & DIGNAT‐GEORGE, F. (2012) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2011.04610.x · Cited by 398 · cited 1×
“MPs contained in SF were not pelleted before labelling to ensure that most of the MPs we analysed (Lacroix et al, 2012).”
Parren, P. W., Warmerdam, P. A., Boeije, L. C., Arts, J., Westerdaal, N. A., Vlug, A., Capel, P. J., Aarden, L. A., & van de Winkel, J. G. (1992) · Journal of Clinical Investigation · doi:10.1172/jci116022 · Cited by 346
Klickstein, L. B., Shapleigh, C., & Goetzl, E. J. (1980) · Journal of Clinical Investigation · doi:10.1172/jci109947 · Cited by 345 · cited 1×
“The inflammatory lipid mediators leukotrienes are present in RA synovial fluid (Klickstein et al, 1980) and its production by neutrophils, a cellular lineage dominant in the synovial fluid from RA patients (Edwards & Hallett, 1997), contribute to the pathophysiology of inflammatory arthritis in in vivo…”
Distler, J. H. W., Jüngel, A., Huber, L. C., Seemayer, C. A., Reich, C. F., Gay, R. E., Michel, B. A., Fontana, A., Gay, S., Pisetsky, D. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409781102 · Cited by 328 · cited 4×
“Since platelet MPs are abundant in autoimmune diseases (Berckmans et al, 2005; Boilard et al, 2010; Distler & Distler, 2010; Distler et al, 2005a; Messer et al, 2009; Reich et al, 2011), they may be a crucial source of autoantigens for the constant autoantibody deposition that perpetuates…”
InfluentialThe role of microparticles in the pathogenesis of rheumatic diseases
Beyer, C., & Pisetsky, D. S. (2010) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2009.229 · Cited by 324 · cited 2×
“Given the universality of this process, MPs likely play essential functions that include cell–cell communication and transportation of mediators (Beyer & Pisetsky, 2010; Distler et al, 2005b; Gyorgy et al, 2011b).”
Seeing the wood for the trees: the forgotten role of neutrophils in rheumatoid arthritis
Edwards, S. W., & Hallett, M. B. (1997) · Immunology Today · doi:10.1016/s0167-5699(97)01087-6 · Cited by 323 · cited 1×
“…are present in RA synovial fluid (Klickstein et al, 1980) and its production by neutrophils, a cellular lineage dominant in the synovial fluid from RA patients (Edwards & Hallett, 1997), contribute to the pathophysiology of inflammatory arthritis in in vivo mechanistic models (Chen et al, 2006).”
Kehrel, B., Wierwille, S., Clemetson, K. J., Anders, O., Steiner, M., Graham Knight, C., Farndale, R. W., Okuma, M., & Barnes, M. J. (1998) · Blood · doi:10.1182/blood.v91.2.491 · Cited by 317 · cited 1×
“Platelets were isolated (Boilard et al, 2011), resuspended at 100 (cid:6) 10 6 /ml in Tyrode’s buffer and stimulated using 0.5 m g/ml cross-linked collagen related peptide (Kehrel et al, 1998) for 120min at RT.”
InfluentialSelf-citationExner, T., Ma, D. D. F., Joseph, J. E., & Connor, D. E. (2010) · Thrombosis and Haemostasis · doi:10.1160/th09-09-0644 · Cited by 293 · cited 3×
“These uncommon features permit the detection of MPs cytofluorometrically by employing Annexin-V (which recognizes phosphatidylserine) conjugated to fluorochromes and size discrimination (Connor et al, 2010; Gyorgy et al, 2011a; Perez-Pujol et al, 2007; Thiagarajan & Tait, 1991).”
Neutrophil-derived leukotriene B4 is required for inflammatory arthritis
Chen, M., Lam, B. K., Kanaoka, Y., Nigrovic, P. A., Audoly, L. P., Austen, K. F., & Lee, D. M. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20052371 · Cited by 287 · cited 1×
“…are present in RA synovial fluid (Klickstein et al, 1980) and its production by neutrophils, a cellular lineage dominant in the synovial fluid from RA patients (Edwards & Hallett, 1997), contribute to the pathophysiology of inflammatory arthritis in in vivo mechanistic models (Chen et al, 2006).”
Self-citationAntigen microarray profiling of autoantibodies in rheumatoid arthritis
Hueber, W., Kidd, B. A., Tomooka, B. H., Lee, B. J., Bruce, B., Fries, J. F., Sønderstrup, G., Monach, P., Drijfhout, J. W., van Venrooij, W. J., et al. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21269 · Cited by 261 · cited 3×
“Using an autoantigen microarray (Hueber et al, 2005; Robinson et al, 2002), we demonstrate that the IgG from platelet mpICs associate with a broad series of recognized citrullinated autoantigens (Fig 6A).”
Self-citationPathogenetic mechanisms in the initiation and perpetuation of Sjögren's syndrome
Voulgarelis, M., & Tzioufas, A. G. (2010) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2010.118 · Cited by 259 · cited 3×
“…at eliciting inflammatory responses and implicated in response to infections as well as multiple autoimmune diseases such as Sjo¨gren’s syndrome (Voulgarelis & Tzioufas, 2010), SLE (Munoz et al, 2010), multiple sclerosis (Cross et al, 2001; Ziemssen & Ziemssen, 2005), antiphospholipid syndrome…”
Association of citrullinated proteins with synovial exosomes
Skriner, K., Adolph, K., Jungblut, P. R., & Burmester, G. R. (2006) · Arthritis & Rheumatism · doi:10.1002/art.22276 · Cited by 259 · cited 1×
“Furthermore, exosomes, vesicles derived from intracellular compartments, also display antigens in RA SF (Skriner et al, 2006).”
B cells and antibodies in CNS demyelinating disease
Cross, A. H., Trotter, J. L., & Lyons, J.-A. (2001) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(00)00409-4 · Cited by 251 · cited 3×
“We observe that the Annexin-V þ particles are promptly solubilized by Triton X-100 treatment, a finding consistent with the membrane composition present in MPs (Fig 1D).”
Knijff‐Dutmer, E. A. J., Koerts, J., Nieuwland, R., Kalsbeek‐Batenburg, E. M., & Van De Laar, M. A. F. J. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10312 · Cited by 250 · cited 2×
“…including systemic lupus erythematosus (SLE; Pereira et al, 2006; Sellam et al, 2009), Sjo¨gren’s syndrome (Sellam et al, 2009), multiple sclerosis (Sheremata et al, 2008), antiphospholipid syndrome (Jy et al, 2007), and RA (Boilard et al, 2010, 2012; Knijff-Dutmer et al, 2002; Sellam et al, 2009).”
Lundberg, K., Nijenhuis, S., Vossenaar, E. R., Palmblad, K., van Venrooij, W. J., Klareskog, L., Zendman, A., & Harris, H. E. (2005) · Arthritis Research & Therapy · doi:10.1186/ar1697 · Cited by 244 · cited 2×
“Specifically, citrullination is a posttranslational modification of peptidyl-arginine to peptidyl-citrulline by peptidyl arginine deiminase (PAD) enzymes; in RA SF, the PAD4 isoform levels are significantly elevated (Arita et al, 2004; Lundberg et al, 2005).”
Sellam, J., Proulle, V., Jüngel, A., Ittah, M., Miceli Richard, C., Gottenberg, J.-E., Toti, F., Benessiano, J., Gay, S., Freyssinet, J.-M., et al. (2009) · Arthritis Research & Therapy · doi:10.1186/ar2833 · Cited by 240 · cited 5×
“Indeed, the MPs derived by platelets in blood during RA (Knijff-Dutmer et al, 2002; Sellam et al, 2009) may accumulate in the SF through the gaps present between the endothelial cells in the inflamed vasculature (Boilard et al, 2012; Cloutier et al, 2012).”
InfluentialPlatelets can enhance vascular permeability
Cloutier, N., Paré, A., Farndale, R. W., Schumacher, H. R., Nigrovic, P. A., Lacroix, S., & Boilard, E. (2012) · Blood · doi:10.1182/blood-2012-02-413047 · Cited by 237 · cited 1×
“Indeed, the MPs derived by platelets in blood during RA (Knijff-Dutmer et al, 2002; Sellam et al, 2009) may accumulate in the SF through the gaps present between the endothelial cells in the inflamed vasculature (Boilard et al, 2012; Cloutier et al, 2012).”
Self-citationDistler, J. H. W., Pisetsky, D. S., Huber, L. C., Kalden, J. R., Gay, S., & Distler, O. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21350 · Cited by 230 · cited 4×
“Since platelet MPs are abundant in autoimmune diseases (Berckmans et al, 2005; Boilard et al, 2010; Distler & Distler, 2010; Distler et al, 2005a; Messer et al, 2009; Reich et al, 2011), they may be a crucial source of autoantigens for the constant autoantibody deposition that perpetuates…”
InfluentialKnight, C. (1999) · Cardiovascular Research · doi:10.1016/s0008-6363(98)00306-x · Cited by 226 · cited 2×
“Since platelets promptly release MPs following stimulation of the collagen receptor glycoprotein VI (GPVI) (Boilard et al, 2010; Knight et al, 1999), and since GPVI deficiency in mice leads to reduction of the severity of arthritis (Boilard et al, 2010), we generated MPs via this arthritis-relevant…”
Platelets: active players in the pathogenesis of arthritis and SLE
Boilard, E., Blanco, P., & Nigrovic, P. A. (2012) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2012.118 · Cited by 223 · cited 4×
“Considering their role in arthritis (Boilard et al, 2010, 2012), we queried whether platelet MPs contribute significantly to mpICs in RA SF.”
InfluentialSelf-citationBrown, G. T., & McIntyre, T. M. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1001623 · Cited by 223 · cited 1×
“Although the recognition of bacterial products by platelets can initiate the production of MPs (Brown & McIntyre, 2011), whether the formation of inflammatory mpICs can occur in a physiologically beneficial manner in the course of the responses against pathogens is unknown.”
Berckmans, R. J., Nieuwland, R., Tak, P. P., Böing, A. N., Romijn, F. P. H. T. M., Kraan, M. C., Breedveld, F. C., Hack, C. E., & Sturk, A. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10587 · Cited by 198
Circulating immune complexes contain citrullinated fibrinogen in rheumatoid arthritis
Zhao, X., Okeke, N. L., Sharpe, O., Batliwalla, F. M., Lee, A. T., Ho, P. P., Tomooka, B. H., Gregersen, P. K., & Robinson, W. H. (2008) · Arthritis Research & Therapy · doi:10.1186/ar2478 · Cited by 182
Self-citationSEHGAL, S., & STORRIE, B. (2007) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2007.02698.x · Cited by 181
Evidence of platelet activation in multiple sclerosis
Sheremata, W. A., Jy, W., Horstman, L. L., Ahn, Y. S., Alexander, J. S., & Minagar, A. (2008) · Journal of Neuroinflammation · doi:10.1186/1742-2094-5-27 · Cited by 176 · cited 1×
“…including systemic lupus erythematosus (SLE; Pereira et al, 2006; Sellam et al, 2009), Sjo¨gren’s syndrome (Sellam et al, 2009), multiple sclerosis (Sheremata et al, 2008), antiphospholipid syndrome (Jy et al, 2007), and RA (Boilard et al, 2010, 2012; Knijff-Dutmer et al, 2002; Sellam et al,…”
Collagen-induced exposure of anionic phospholipid in platelets and platelet-derived microparticles.
Thiagarajan, P., & Tait, J. F. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)54228-9 · Cited by 168 · cited 1×
“These uncommon features permit the detection of MPs cytofluorometrically by employing Annexin-V (which recognizes phosphatidylserine) conjugated to fluorochromes and size discrimination (Connor et al, 2010; Gyorgy et al, 2011a; Perez-Pujol et al, 2007; Thiagarajan & Tait, 1991).”
Nielsen, C. T., Østergaard, O., Stener, L., Iversen, L. V., Truedsson, L., Gullstrand, B., Jacobsen, S., & Heegaard, N. H. H. (2012) · Arthritis & Rheumatism · doi:10.1002/art.34381 · Cited by 167 · cited 2×
“The presence of immunoglobulins on surface of MPs in blood during RA has been previously examined (Nielsen et al, 2012; van Eijk et al, 2010).”
Ullal, A. J., Reich, C. F., Clowse, M. E. B., Criscione‐Schreiber, L. G., Tochacek, M., Monestier, M., & Pisetsky, D. S. (2011) · Journal of Autoimmunity · doi:10.1016/j.jaut.2011.02.001 · Cited by 165
Perez‐Pujol, S., Marker, P. H., & Key, N. S. (2007) · Cytometry Part A · doi:10.1002/cyto.a.20354 · Cited by 161 · cited 1×
“Platelet MPs in particular were observed in autoimmune disorders including systemic lupus erythematosus (SLE; Pereira et al, 2006; Sellam et al, 2009), Sjögren’s syndrome (Sellam et al, 2009), multiple sclerosis (Sheremata et al, 2008), antiphospholipid syndrome (Jy et al, 2007), and RA (Boilard…”
BackgroundAlfaro, G., Goycoolea, M., Quiroga, T., Ocqueteau, M., Massardo, L., Pérez, C., Sáez, C., Panes, O., Matus, V., Mezzano, D., et al. (2006) · Thrombosis and Haemostasis · doi:10.1160/th05-05-0310 · Cited by 157 · cited 1×
“Platelet MPs in particular were observed in autoimmune disorders including systemic lupus erythematosus (SLE; Pereira et al, 2006; Sellam et al, 2009), Sjo¨gren’s syndrome (Sellam et al, 2009), multiple sclerosis (Sheremata et al, 2008), antiphospholipid syndrome (Jy et al, 2007), and RA (Boilard…”
Berckmans, R. J., Nieuwland, R., Kraan, M. C., Schaap, M. C., Pots, D., Smeets, T. J., Sturk, A., & Tak, P. P. (2005) · Arthritis Research & Therapy · doi:10.1186/ar1706 · Cited by 157 · cited 1×
“Since platelet MPs are abundant in autoimmune diseases (Berckmans et al, 2005; Boilard et al, 2010; Distler & Distler, 2010; Distler et al, 2005a; Messer et al, 2009; Reich et al, 2011), they may be a crucial source of autoantigens for the constant autoantibody deposition that perpetuates…”
Takizawa, Y., Suzuki, A., Sawada, T., Ohsaka, M., Inoue, T., Yamada, R., & Yamamoto, K. (2006) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2005.044743 · Cited by 135 · cited 1×
“Among these autoantigens present in platelet mpICs and recognized by the IgG eluted from platelet mpICs, we focused our attention on the two previously described autoantigens vimentin (El-Gabalawy & Wilkins, 2004; Kurki et al, 1983) and fibrinogen (Takizawa et al, 2006).”
Flamand, N., Surette, M. E., Picard, S., Bourgoin, S. G., & Borgeat, P. (2002) · Molecular Pharmacology · doi:10.1124/mol.62.2.250 · Cited by 128 · cited 1×
“Human neutrophils isolation and leukotriene quantifications were determined as described (Boyum, 1968; Flamand et al, 2002).”
Podor, T. J., Singh, D., Chindemi, P., Foulon, D. M., McKelvie, R., Weitz, J. I., Austin, R., Boudreau, G., & Davies, R. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109675200 · Cited by 127 · cited 1×
“Vimentin is an intracellular cytoskeleton protein expressed on the surface of platelet-derived MPs (Podor et al, 2002) and autoantibodies directed against citrullinated-vimentin are present in RA SF (El-Gabalawy & Wilkins, 2004; Kurki et al, 1983).”
Ziemssen, T., & Ziemssen, F. (2005) · Autoimmunity Reviews · doi:10.1016/j.autrev.2005.03.005 · Cited by 115 · cited 2×
“…autoimmune disorders and are reported to propagate disease (Cross et al, 2001; Ho et al, 2010; Korganow et al, 1999; Kuhn et al, 2006; Monach et al, 2009; Munoz et al, 2010; Ruiz-Irastorza et al, 2010; Stuart & Dixon, 1983; Voulgarelis & Tzioufas, 2010; Zhao et al, 2008; Ziemssen & Ziemssen, 2005).”
Boilard, E., Bourgoin, S. G., Bernatchez, C., & Surette, M. E. (2003) · Blood · doi:10.1182/blood-2002-12-3702 · Cited by 111 · cited 1×
“Small apoptotic CD3 þ T cells, for instance, expose vimentin (Boilard et al, 2003) and could potentially interact with anti-vimentin autoantibodies if present in RA SF.”
Biró, É., Nieuwland, R., Tak, P. P., PRONK, L. M., Schaap, M. C. L., Sturk, A., & Hack, C. E. (2007) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2006.061309 · Cited by 102 · cited 1×
“Others had suggested that complement and immunoglobulins were associated with the substantial majority of MPs in RA SF (Biro et al, 2007).”
Monach, P. A., Hueber, W., Kessler, B. M., Tomooka, B. H., BenBarak, M. J., Simmons, B. P., Wright, J., Thornhill, T. S., Monestier, M., Ploegh, H. L., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0908032106 · Cited by 98 · cited 4×
“Using an autoantigen microarray (Hueber et al, 2005; Robinson et al, 2002), we demonstrate that the IgG from platelet mpICs associate with a broad series of recognized citrullinated autoantigens (Fig 6A).”
InfluentialSelf-citationBodary, S. C., Napier, M. A., & McLean, J. W. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)47233-5 · Cited by 85 · cited 1×
“While fibrinogen is a ligand of the platelet integrins GPIIb/IIIa (Bodary et al, 1989), we confirmed that fibrinogen interacts with platelet MPs.”
Microparticle-induced release of B-lymphocyte regulators by rheumatoid synoviocytes
Messer, L., Alsaleh, G., Freyssinet, J., Zobairi, F., Leray, I., Gottenberg, J., Sibilia, J., Toti, F., & Wachsmann, D. (2009) · Arthritis Research & Therapy · doi:10.1186/ar2648 · Cited by 72 · cited 2×
“Since platelet MPs are abundant in autoimmune diseases (Berckmans et al, 2005; Boilard et al, 2010; Distler & Distler, 2010; Distler et al, 2005a; Messer et al, 2009; Reich et al, 2011), they may be a crucial source of autoantigens for the constant autoantibody deposition that perpetuates…”
Jy, W., Tiede, M. P., Bidot, C., Horstman, L. L., Jimenez, J. J., Chirinos, J. A., & Ahn, Y. S. (2007) · Thrombosis Research · doi:10.1016/j.thromres.2007.04.014 · Cited by 70 · cited 1×
“…including systemic lupus erythematosus (SLE; Pereira et al, 2006; Sellam et al, 2009), Sjo¨gren’s syndrome (Sellam et al, 2009), multiple sclerosis (Sheremata et al, 2008), antiphospholipid syndrome (Jy et al, 2007), and RA (Boilard et al, 2010, 2012; Knijff-Dutmer et al, 2002; Sellam et al, 2009).”
Autoimmunity to citrullinated type II collagen in rheumatoid arthritis
Yoshida, M., Tsuji, M., Kurosaka, D., Kurosaka, D., Yasuda, J., Ito, Y., Nishizawa, T., & Yamada, A. (2006) · Modern Rheumatology · doi:10.1007/s10165-006-0498-y · Cited by 70 · cited 1×
“Among the mechanisms that occur in RA SF and not in PA SF is citrullination, a process that generates neoepitopes recognized by autoantibodies present in abundance in many patients with RA (Yoshida et al, 2006).”
Borgeat, P., Picard, S., Vallerand, P., Bourgoin, S. G., Odeimat, A., Sirois, P., & Epoubelle, P. (1990) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/0076-6879(90)87014-t · Cited by 68 · cited 1×
“Samples were stored at (cid:4) 20 8 C O/N then analysed by reverse-phase HPLC as previously described (Borgeat et al, 1990).”
Autoimmunity against Fibrinogen Mediates Inflammatory Arthritis in Mice
Ho, P. P.-K., Lee, L. Y., Zhao, X., Tomooka, B. H., Paniagua, R. T., Sharpe, O., BenBarak, M. J., Chandra, P. E., Hueber, W., Steinman, L., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901639 · Cited by 65 · cited 3×
“…of MPs (Berck-mans et al, 2005; Boilard et al, 2010; Distler & Distler, 2010; Distler et al, 2005a; Messer et al, 2009; Reich et al, 2011) and IC (Ho et al, 2010; Korganow et al, 1999; Kuhn et al, 2006; Stuart & Dixon, 1983) when taken separately, our identification of mpICs in synovial fluid…”
Self-citationAntibodies to cytoplasmic intermediate filaments in rheumatic diseases.
Kurki, P., Helve, T., & Virtanen, I. (1983) · PubMed · Cited by 65
Influence of tyrosine phosphorylation on protein interaction with FcγRIIa
Ibarrola, I., Vossebeld, P. J. M., Homburg, C., Thelen, M., Roos, D., & Verhoeven, A. J. (1997) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/s0167-4889(97)00034-7 · Cited by 63 · cited 1×
“One microgram of sample was lysed in Laemmli buffer, electrophoresed, transferred onto membranes and incubated in 0.2% milk/TBS-Tween solution containing a serum raised against a peptide in the cytoplasmic domain of CD32a (CT10; Ibarrola et al, 1997).”
InfluentialAutoimmunity to citrullinated type II collagen in rheumatoid arthritis
Yoshida, M., Tsuji, M., Kurosaka, D., et al. (2006) · Modern Rheumatology · doi:10.3109/s10165-006-0498-y · Cited by 54
Microparticles stimulate angiogenesis by inducing ELR+ CXC-chemokines in synovial fibroblasts
Reich, N., Beyer, C., Gelse, K., Akhmetshina, A., Dees, C., Zwerina, J., Schett, G. A., Distler, O., & Distler, J. H. W. (2010) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2010.01051.x · Cited by 53 · cited 2×
“…are abundant in autoimmune diseases (Berckmans et al, 2005; Boilard et al, 2010; Distler & Distler, 2010; Distler et al, 2005a; Messer et al, 2009; Reich et al, 2011), they may be a crucial source of autoantigens for the constant autoantibody deposition that perpetuates inflammation in chronic…”
Boilard, É., Larabee, K. S., Shnayder, R., Jacobs, K., Farndale, R. W., Ware, J. L., & Lee, D. M. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1002857 · Cited by 47 · cited 1×
“Platelets were isolated (Boilard et al, 2011), resuspended at 100 (cid:6) 10 6 /ml in Tyrode’s buffer and stimulated using 0.5 m g/ml cross-linked collagen related peptide (Kehrel et al, 1998) for 120min at RT.”
InfluentialSelf-citationvan Eijk, I. C., Tushuizen, M. E., Sturk, A., Dijkmans, B. A. C., Boers, M., Voskuyl, A. E., Diamant, M., Wolbink, G., Nieuwland, R., & Nurmohamed, M. T. (2009) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2009.118372 · Cited by 42
Human platelet FcγRIIA and phagocytes in immune-complex clearance
Huang, Z.-Y., Chien, P., Indik, Z. K., & Schreiber, A. D. (2010) · Molecular Immunology · doi:10.1016/j.molimm.2010.11.017 · Cited by 39 · cited 2×
“Together, these results identify a unique site of autoantigen expression in RA and suggest that MPs, including those derived from platelets, may participate in the generation of a novel type of potent ICs in this disease.”
BackgroundAnti-Sa antibodies: prognostic and pathogenetic significance to rheumatoid arthritis.
El-Gabalawy, H. S., & Wilkins, J. A. (2004) · Arthritis Research · doi:10.1186/ar1171 · Cited by 35 · cited 2×
“Among these autoantigens present in platelet mpICs and recognized by the IgG eluted from platelet mpICs, we focused our attention on the two previously described autoantigens vimentin (El-Gabalawy & Wilkins, 2004; Kurki et al, 1983) and fibrinogen (Takizawa et al, 2006).”
Microparticles and their roles in inflammatory arthritides
Distler, J. H. W., & Distler, O. (2010) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2010.87 · Cited by 30 · cited 2×
“Since platelet MPs are abundant in autoimmune diseases (Berckmans et al, 2005; Boilard et al, 2010; Distler & Distler, 2010; Distler et al, 2005a; Messer et al, 2009; Reich et al, 2011), they may be a crucial source of autoantigens for the constant autoantibody deposition that perpetuates…”
Innate Immunity And Immune Complexes In Rheumatoid Arthritis
Nigrovic, P. A., & Lee, D. M. (2006) · doi:10.1093/oso/9780198566304.003.0010 · Cited by 7
Self-citation
Cited by
Biological properties of extracellular vesicles and their physiological functions
Yáñez‐Mó, M., Siljander, P. R. ‐., Andreu, Z., Bedina Zavec, A., Borràs, F. E., Buzas, E. I., Buzas, K., Casal, E., Cappello, F., Carvalho, J., et al. (2015) · Journal of Extracellular Vesicles · doi:10.3402/jev.v4.27066 · Cited by 5,926
“5) inducing or propagating inflammatory signals during infections (391,392), sepsis (393,394), chronic inflammatory diseases, such as RA (395,396), atherosclerosis (397), type 2 diabetes (398) and pre-eclampsia (399).”
BackgroundWitwer, K. W., Buzás, E. I., Bemis, L. T., Bora, A., Lässer, C., Lötvall, J., Nolte‐‘t Hoen, E. N., Piper, M. G., Sivaraman, S., Skog, J., et al. (2013) · Journal of Extracellular Vesicles · doi:10.3402/jev.v2i0.20360 · Cited by 2,421
“The latter enables the analysis of EV in frozen samples with the advantage of avoiding the effects of dehydration and chemical fixatives (250).”
Extracellular vesicles as tools and targets in therapy for diseases
Kumar, M. A., Baba, S. K., Sadida, H. Q., Marzooqi, S. A., Jerobin, J., Altemani, F. H., Algehainy, N., Alanazi, M. A., Abou-Samra, A.-B., Kumar, R., et al. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01735-1 · Cited by 1,343
Circulating Platelets as Mediators of Immunity, Inflammation, and Thrombosis
Koupenova, M., Clancy, L., Corkrey, H. A., & Freedman, J. E. (2018) · Circulation Research · doi:10.1161/circresaha.117.310795 · Cited by 980
Boudreau, L. H., Duchez, A.-C., Cloutier, N., Soulet, D., Martin, N., Bollinger, J., Paré, A., Rousseau, M., Naika, G. S., Lévesque, T., et al. (2014) · Blood · doi:10.1182/blood-2014-05-573543 · Cited by 703
Self-citation
Metadata
- Authors
- Cloutier, N., Tan, S., Boudreau, L. H., Cramb, C., Subbaiah, R., Lahey, L., Albert, A., Shnayder, R., Gobezie, R., Nigrovic, P. A., Farndale, R. W., Robinson, W. H., Brisson, A., Lee, D. M., & Boilard, E.
- Affiliations
- Centre hospitalier universitaire de Québec (CA)
- Chimie et Biologie des Membranes et des Nanoobjects (FR)
- Stanford Medicine (US)
- Case Western Reserve University (US)
- Brigham and Women's Hospital (US)
- University Hospitals of Cleveland (US)
- University of Cambridge (GB)
- ORCID
- Venue
- EMBO Molecular Medicine
- Published
- 2012-12-11
- Volume
- 5
- Issue
- 2
- Pages
- 235-249
- ISSN
- 1757-4676 (ISSN-L)
- 1757-4684
- PMC
- PMC3569640
- OpenAlex
- W2123391301
- Cited by
- 254
- References
- 72
- Citations by year
- 2026: 6 · 2025: 10 · 2024: 14 · 2023: 18 · 2022: 27 · 2021: 21 · 2020: 21 · 2019: 26 · 2018: 26 · 2017: 23 · 2016: 27 · 2015: 22 · 2014: 6 · 2013: 7
- FWCI
- 8.61
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/3.0/ (tdm)
- creativecommons.org/licenses/by/3.0/ (vor)
- Locations
- EMBO Molecular Medicine (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Funders
- Arthritis Society
- British Heart Foundation (RG/09/003/27122)
- National Institutes of Health (5p01ai065858-05, AI065858)
- Canadian Institutes of Health Research
- National Institute of Allergy and Infectious Diseases (P01 AI-065858)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01AR065538)
- Canadian Arthritis Network
- Topics
- Health Sciences › Medicine › Rheumatology › Systemic Lupus Erythematosus Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
- Health Sciences › Medicine › Rheumatology › Rheumatoid Arthritis Research and Therapies
- Keywords
- microparticles, immune complexes, rheumatoid arthritis, platelets, autoantigens, vimentin, fibrinogen, anti-citrullinated protein antibodies, synovial fluid, CD41, FcγRIIa, neutrophil activation, leukotriene biosynthesis, inflammation, autoimmune arthritis, extracellular vesicles
- MeSH terms
- Antigen-Antibody Complex, Arthritis, Rheumatoid, Autoantigens, Humans, Particle Size, Synovial Fluid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.